Immunohistochemical study of cell cycle regulatory proteins in intraductal breast carcinomas--a preliminary study (Q47805160)

5 February 2018

title

Immunohistochemical study of cell cycle regulatory proteins in intraductal breast carcinomas--a preliminary study (English)

1 reference

5 February 2018

1 reference

Chasle J

1

1 reference

5 February 2018

Delozier T

2

1 reference

5 February 2018

Denoux Y

3

1 reference

5 February 2018

Marnay J

4

1 reference

5 February 2018

Michels JJ

5

1 reference

5 February 2018

publication date

1 July 2003

1 reference

5 February 2018

European Journal of Cancer

published in

1 reference

5 February 2018

volume

39

1 reference

5 February 2018

issue

10

1 reference

5 February 2018

page(s)

1363-1369

1 reference

5 February 2018

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

A prognostic index for ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: A comparative study with long follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Consensus Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, April 22-25, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Prognostic classification of breast ductal carcinoma-in-situ

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Cyclins, cyclin-dependent kinases and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

How p53 suppresses cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Different proliferative patterns characterize different preinvasive breast lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Cyclin D1 expression in ductal carcinoma in situ, atypical ductal hyperplasia and usual ductal hyperplasia: an immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Expression of p21Waf1, p27Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ: Relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

p53 protein expression and nuclear DNA content in breast intraductal proliferations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

Comparison of the prognostic value of four methods to assess mitotic activity in 186 invasive breast cancer patients: classical and random mitotic activity assessments with correction for volume percentage of epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900774-8

7 January 2021

10.1016/S0959-8049(02)00774-8

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018